SCHEMBL22043753

SCHEMBL22043753

N/C=N\N=C(/N)c1ccc(C(=O)O)c(F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 1/20 0.39
▸ NR1H4 Q96RI1 1/20 0.39
▸ NEU3 Q9UQ49 1/20 0.37
▸ HDAC1 Q13547 3/20 0.36
▸ HDAC6 Q9UBN7 3/20 0.36
▸ RARB P10826 3/20 0.36
▸ RARA P10276 2/20 0.36
▸ RARG P13631 2/20 0.36
▸ DGAT1 O75907 1/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ LMNA P02545 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ MYC P01106 4/20 0.33
▸ KEAP1 Q14145 1/20 0.33
▸ CES2 O00748 1/20 0.33
▸ CES1 P23141 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22043759 0.90 DGAT1 (0.46) NEU3HDAC1HDAC6DGAT1CES2
SCHEMBL24022755 0.85 NEU3 (0.46) EPHX2NR1H4NEU3HDAC1HDAC6
SCHEMBL22043785 0.83 KDM4E (0.42) NEU3HDAC1HDAC6ALDH1A1HPGD
SCHEMBL9902629 0.80 KDM1A (0.42) EPHX2NR1H4HDAC1HDAC6RARB
SCHEMBL19014876 0.80 KDM1A (0.42) EPHX2NR1H4HDAC1HDAC6RARB
SCHEMBL24022848 0.77 HDAC1 (0.50) HDAC1HDAC6ALDH1A1HSD17B10LMNA
SCHEMBL24022830 0.76 MKNK1 (0.38) NEU3ALDH1A1HPGDLMNAHTT
SCHEMBL392941 0.76 DGAT1 (0.48) EPHX2NR1H4RARBRARARARG
SCHEMBL24022836 0.75 HDAC1 (0.62) NEU3HDAC1HDAC6MAPK1ALDH1A1
SCHEMBL24022845 0.73 RAB9A (0.50) MAPK1ALDH1A1LMNAHTTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021228992-A1 NUCLIDE LABELLED H-TETRAZINES AND USE THEREOF FOR PET AND SPECT PRETARGETED IMAGING AND RADIONUCLIDE THERAPY RIGSHOSPITALET (DK) 2021-11-18 — — WO disclosed
EP-3909944-A1 NUCLIDE LABELLED H-TETRAZINES AND USE THEREOF FOR PET AND SPECT PRETARGETED IMAGING AND RADIONUCLIDE THERAPY Rigshospitalet (DK) 2021-11-17 — — EP disclosed
WO-2020108720-A1 NOVEL TETRAZINE COMPOUNDS FOR IN VIVO IMAGING Københavns Universitet (DK) 2020-06-04 — — WO disclosed
Send feedback